An article in Tuesday's Business section about Gene Logic Inc.'s preliminary fourth-quarter and year-end financial results incorrectly reported that the company had planned to amortize its entire purchase of Oncormed Inc. In fact, the company plans to amortize only a portion of the $39.1 million purchase, specifically $3.9 million in "good will."

The Sun regrets the error.

Pub Date: 3/11/99